$80.5 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.9 Million
Cardiff Oncology Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.5 Million
Chiasma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Altimmune, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Harpoon Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$62.2 Million
Aptose Biosciences Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$76.3 Million
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.1 Million
Otonomy, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.0 Million
NantKwest (acquired by ImmunityBio)
Confidentially Marketed Follow-On Offering
Left Bookrunner
$40.0 Million
Leap Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.